❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ G. Mælandsmo's group ❭ Research interests ❭

Our major areas of interest are:

Treatment Resistance and Metastasis-Involved Mechanisms

  • Cellular plasticity 
    • Breast cancer and melanoma
    • Prostate cancer
  • Metastasis-associated proteins
  • Immune checkpoint protein B7-H3 as novel therapeutic target in cancer

Word cloud from articles published by the group the past 10 years

Experimental Cancer Therapy

  • Nanoparticle-based drug delivery
  • Breast cancer
  • Prostate cancer

Precision Cancer Medicine

  • Clinical studies in breast cancer
  • Clinical studies in melanoma
  • Metaction
  • Biomarker studies in clinical cohorts
    • Breast cancer biomarkers
    • Biomarkers in melanoma
    • Brain metastasis
    • Prostate cancer biomarkers
 
Scroll to top

Home Dept. of Tumor Biology G. Mælandsmo's group

  • Group members
  • Research interests
  • Publications
  • Links

Recent publications

Torices L, Nunes-Xavier CE, Pulido R (2025)
Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons From Tumor Suppressor Genes
IUBMB Life, 77 (5), e70018
DOI 10.1002/iub.70018, PubMed 40317855

Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622

Pallarès-Sastre M, Amayra I, Pulido R, Nunes-Xavier CE, Bañuelos S, Cavaliere F, García M (2025)
Novel CTNNB1 Gene Variants in Spanish CTNNB1 Syndrome Patients: Clinical and Psychological Manifestations
J Autism Dev Disord (in press)
DOI 10.1007/s10803-025-06829-5, PubMed 40240530



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)